Mikko Myllymäki

Years Active: 2020-2021
Publications (10 Years): 2

Dana Farber Cancer Institute

University of Oulu (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Sep 01 2017 - Sep 01 2019

United States

Postdoctoral Researcher :: Department of Medical Oncology

Education History

University of Oulu Sep 01 2010 - Jun 17 2016

Finland

PHD :: Faculty of Medicine

Publications

Christopher R Reilly, Mikko Myllymäki, Robert A Redd, Shilpa Padmanaban, Druha Karunakaran, Valerie Tesmer, Frederick D Tsai, Christopher J Gibson, Huma Q Rana, Liang Zhong, Wael Saber, Stephen R Spellman, Zhen-Huan Hu, Esther H Orr, Maxine M Chen, Immaculata De Vivo, Daniel J DeAngelo, Corey Cutler, Joseph H Antin, Donna Neuberg, Judy E Garber, Jayakrishnan Nandakumar, Suneet Agarwal, R Coleman Lindsley
The clinical and functional effects of TERT variants in myelodysplastic syndrome. Blood 138 (10) (2021)
Daehong Kim, Giljun Park, Jani Huuhtanen, Sofie Lundgren, Rajiv K Khajuria, Ana María Hurtado López, Cecilia Muñoz-Calleja, Laura Cardeñoso, Valle Gómez-García de Soria, Tzu Hua Chen-Liang, Samuli Eldfors, Pekka Ellonen, Sari Hannula, Matti Kankainen, Oscar Brück, Anna Kreutzman, Urpu Salmenniemi, Tapio Lönnberg, Andrés Jerez, Maija Itälä-Remes, Mikko Myllymäki, Mikko A I Keränen, Mohamed El Missiry
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. Nature communications 11 (1) (2020)

Mikko Myllymäki.css-eqlu8i{font-size:small;padding-left:4px;}